Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence for intermediate channeling in mitochondrial beta-oxidation

M A Nada1, W J Rhead, H Sprecher

  • 1Department of Pediatrics, Duke University Medical Center, Research Triangle Park, North Carolina 27709.

The Journal of Biological Chemistry
|January 13, 1995
PubMed
Summary

Beta-oxidation enzyme deficiencies in human cells lead to specific accumulations of fatty acid intermediates. This study reveals how these enzyme defects impact the beta-oxidation pathway and intermediate channeling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.

Neurology·2008
Same author

Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.

Molecular genetics and metabolism·2005
Same author

Respiratory complex II defect in siblings associated with a symptomatic secondary block in fatty acid oxidation.

Journal of inherited metabolic disease·2004
Same author

Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.

Prenatal diagnosis·2001
Same author

Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype.

Clinica chimica acta; international journal of clinical chemistry·2001
Same author

Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family.

Molecular genetics and metabolism·2001

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Disorders

Background:

  • Beta-oxidation is a crucial metabolic pathway for fatty acid breakdown.
  • Defects in beta-oxidation enzymes cause various inherited metabolic disorders.
  • Understanding intermediate accumulation is key to diagnosing and treating these conditions.

Purpose of the Study:

  • To investigate the accumulation patterns of beta-oxidation intermediates in normal and enzyme-deficient human fibroblasts.
  • To elucidate the role of enzyme organization and intermediate channeling in the beta-oxidation pathway.
  • To identify specific acylcarnitine signatures associated with different beta-oxidation enzyme deficiencies.

Main Methods:

  • Incubation of human fibroblasts (normal and enzyme-deficient) with labeled linoleate and L-carnitine.

Related Experiment Videos

  • Analysis of resultant acylcarnitines using tandem mass spectrometry.
  • Quantification and identification of specific beta-oxidation intermediates.

    • Main Results:

    • Normal cells showed limited accumulation of short-chain beta-oxidation intermediates.
    • Deficiencies in inner mitochondrial membrane enzymes led to the accumulation of longer-chain intermediates.
    • Matrix enzyme deficiencies resulted in elevated concentrations of specific substrate-related acylcarnitines.
    • Evidence of intermediate channeling within beta-oxidation enzyme complexes was observed, with an exception in matrix enzyme interactions.

    Conclusions:

    • Beta-oxidation enzyme deficiencies cause distinct patterns of intermediate accumulation.
    • Intermediate channeling is a significant feature of the beta-oxidation pathway.
    • Specific acylcarnitine profiles can diagnose defects in beta-oxidation enzymes.
    • Incomplete channeling between matrix enzymes may result from limited enzyme interactions.